Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01159613|
Recruitment Status : Completed
First Posted : July 9, 2010
Last Update Posted : July 9, 2010
|Condition or disease||Intervention/treatment|
|Chronic Hepatitis C Viral Infection||Other: Responders Other: Non Responders|
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection.
Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?|
|Study Start Date :||April 2008|
|Primary Completion Date :||October 2008|
|Study Completion Date :||January 2009|
Other: Non Responders
- sustained viral response [ Time Frame: 72 weeks ]achieving SVR
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01159613
|Ziv medical center liver unit|
|Safed, Israel, Israel|